{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:52:46Z","timestamp":1791643966026,"version":"4.3.4"},"reference-count":69,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":139,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific & Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.csbj.2021.05.037","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T04:36:18Z","timestamp":1621830978000},"page":"3133-3148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning"],"prefix":"10.34133","volume":"19","author":[{"given":"Akanksha","family":"Rajput","sequence":"first","affiliation":[{"name":"Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamika","family":"Thakur","sequence":"additional","affiliation":[{"name":"Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India"},{"name":"Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adhip","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India"},{"name":"Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Kamboj","sequence":"additional","affiliation":[{"name":"Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India"},{"name":"Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Rastogi","sequence":"additional","affiliation":[{"name":"Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India"},{"name":"Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Gautam","sequence":"additional","affiliation":[{"name":"Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India"},{"name":"Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvinder","family":"Jassal","sequence":"additional","affiliation":[{"name":"Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India"},{"name":"Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2021,6,2]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2016.81"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1073\/pnas.0805270106","article-title":"Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion","volume":"106","author":"Barcena M.","year":"2009","unstructured":"Barcena M., Oostergetel G.T., Bartelink W., Faas F.G.A., Verkleij A., Rottier P.J.M. et al: Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion. Proc Natl Acad Sci U S A 2009; 106: 582.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00645-06"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06540-11"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg","volume":"9","author":"Chan J.-W.","year":"2020","unstructured":"Chan J.-W., Kok K.-H., Zhu Z., Chu H., To K.-W., Yuan S. et al: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect 2020; 9: 221.","journal-title":"Microbes Infect"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30251-8"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(06)66005-3"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2004.09.009"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.058"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature17200"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.26"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"110195","DOI":"10.1016\/j.biopha.2020.110195","article-title":"New understanding of the damage of SARS-CoV-2 infection outside the respiratory system","volume":"127","author":"Zhang Y.","year":"2020","unstructured":"Zhang Y., Geng X., Tan Y., Li Q., Xu C., Xu J. et al: New understanding of the damage of SARS-CoV-2 infection outside the respiratory system. Biomed Pharmacother 2020; 127: 110195.","journal-title":"Biomed Pharmacother"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan T.P.","year":"2020","unstructured":"Sheahan T.P., Sims A.C., Leist S.R., Sch\u00e4fer A., Won J., Brown A.J. et al: Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun 2020; 11.","journal-title":"Nat Commun"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0282-0"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent M.J.","year":"2005","unstructured":"Vincent M.J., Bergeron E., Benjannet S., Erickson B.R., Rollin P.E., Ksiazek T.G. et al: Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2005; 2: 69.","journal-title":"Virol J"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03011-14"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"105923","DOI":"10.1016\/j.ijantimicag.2020.105923","article-title":"Chloroquine for the 2019 novel coronavirus SARS-CoV-2","volume":"55","author":"Colson P.","year":"2020","unstructured":"Colson P., Rolain J.-M. and Raoult D.: Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents 2020; 55: 105923.","journal-title":"Int J Antimicrob Agents"},{"key":"e_1_3_4_19_2","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu J.","year":"2020","unstructured":"Liu J., Cao R., Xu M., Wang X.i., Zhang H., Hu H. et al: Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov 2020; 6.","journal-title":"Cell Discov"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.2174\/0929867327666200416131117","article-title":"SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir\/Ritonavir, Darunavir\/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus","volume":"27","author":"Costanzo M.","year":"2020","unstructured":"Costanzo M., De Giglio M.A.R. and Roviello G.N.: SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir\/Ritonavir, Darunavir\/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus. Curr Med Chem 2020; 27: 4536.","journal-title":"Curr Med Chem"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu C.M.","year":"2004","unstructured":"Chu C.M., Cheng V.C.C., Hung I.F.N., Wong M.M.L., Chan K.H., Chan K.S. et al: Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004; 59: 252.","journal-title":"Thorax"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3851\/IMP3002","article-title":"Combination therapy with lopinavir\/ritonavir, ribavirin and interferon-\u03b1 for Middle East respiratory syndrome","volume":"21","author":"Kim U.J.","year":"2016","unstructured":"Kim U.J., Won E.-J., Kee S.-J., Jung S.-I. and Jang H.-C.: Combination therapy with lopinavir\/ritonavir, ribavirin and interferon-\u03b1 for Middle East respiratory syndrome. Antivir Ther 2016; 21: 455.","journal-title":"Antivir Ther"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-017-2427-0","article-title":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-\u03b21b (MIRACLE trial): study protocol for a randomized controlled trial","volume":"19","author":"Arabi Y.M.","year":"2018","unstructured":"Arabi Y.M., Alothman A., Balkhy H.H., Al-Dawood A., AlJohani S., Al Harbi S. et al: Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-\u03b21b (MIRACLE trial): study protocol for a randomized controlled trial. Trials 2018; 19.","journal-title":"Trials"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","volume":"395","author":"Hung I.-N.","year":"2020","unstructured":"Hung I.-N., Lung K.-C., Tso E.-K., Liu R., Chung T.-H., Chu M.-Y. et al: Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet 2020; 395: 1695.","journal-title":"Lancet"},{"key":"e_1_3_4_25_2","first-page":"8592","article-title":"Lopinavir\/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review","volume":"24","author":"Vargas M.","year":"2020","unstructured":"Vargas M., Servillo G. and Einav S.: Lopinavir\/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review. Eur Rev Med Pharmacol Sci 2020; 24: 8592.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"100345","DOI":"10.1016\/j.imu.2020.100345","article-title":"Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study","volume":"19","author":"Peele K.A.","year":"2020","unstructured":"Peele K.A., Potla Durthi C., Srihansa T., Krupanidhi S., Ayyagari V.S., Babu D.J. et al: Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study. Inform Med Unlocked 2020; 19: 100345.","journal-title":"Inform Med Unlocked"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"104451","DOI":"10.1016\/j.meegid.2020.104451","article-title":"Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches","volume":"84","author":"Bhowmik D.","year":"2020","unstructured":"Bhowmik D., Nandi R., Jagadeesan R., Kumar N., Prakash A. and Kumar D.: Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches. Infect Genet Evol 2020; 84: 104451.","journal-title":"Infect Genet Evol"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","unstructured":"Thakur N Qureshi A Kumar M. AVPpred: collection and prediction of highly effective antiviral peptides. Nucleic Acids Res 2012;40:W199\u2013204.","DOI":"10.1093\/nar\/gks450"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/bip.22703","article-title":"AVP-IC50 Pred: Multiple machine learning techniques-based prediction of peptide antiviral activity in terms of half maximal inhibitory concentration (IC50)","volume":"104","author":"Qureshi A.","year":"2015","unstructured":"Qureshi A., Tandon H. and Kumar M.: AVP-IC50 Pred: Multiple machine learning techniques-based prediction of peptide antiviral activity in terms of half maximal inhibitory concentration (IC50). Biopolymers 2015; 104: 753.","journal-title":"Biopolymers"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","unstructured":"Qureshi A Rajput A Kaur G Kumar M. HIVprotI: an integrated web based platform for prediction and design of HIV proteins inhibitors. J Cheminform 2018;10:12.","DOI":"10.1186\/s13321-018-0266-y"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.3389\/fmicb.2018.03121","article-title":"Anti-flavi: A Web Platform to Predict Inhibitors of Flaviviruses Using QSAR and Peptidomimetic Approaches","volume":"9","author":"Rajput A.","year":"2018","unstructured":"Rajput A. and Kumar M.: Anti-flavi: A Web Platform to Predict Inhibitors of Flaviviruses Using QSAR and Peptidomimetic Approaches. Front Microbiol 2018; 9: 3121.","journal-title":"Front Microbiol"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","unstructured":"Gupta AK Khan MS Choudhury S Mukhopadhyay A Sakshi Rastogi A et al. CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2. Front Microbiol 2020;11. https:\/\/doi.org\/10.3389\/fmicb.2020.01858.","DOI":"10.3389\/fmicb.2020.01858"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","unstructured":"Rajput A Kumar A Megha K Thakur A Kumar M. DrugRepV: a compendium of repurposed drugs and chemicals targeting epidemic and pandemic viruses. Brief Bioinform 2021. https:\/\/doi.org\/10.1093\/bib\/bbaa421.","DOI":"10.1093\/bib\/bbaa421"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","unstructured":"Peeri NC Shrestha N Rahman MS Zaki R Tan Z Bibi S et al. The SARS MERS and novel coronavirus (COVID-19) epidemics the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol 2020;49:717\u201326.","DOI":"10.1093\/ije\/dyaa033"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","unstructured":"Gu C Wu Y Guo H Zhu Y Xu W Wang Y et al. Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection and in a mouse model expressing human ACE2. Sci Bull (Beijing) 2020. https:\/\/doi.org\/10.1016\/j.scib.2020.12.005.","DOI":"10.1016\/j.scib.2020.12.005"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0039-6257(00)00158-2","article-title":"Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration","volume":"45","author":"Schmidt-Erfurth U.","year":"2000","unstructured":"Schmidt-Erfurth U. and Hasan T.: Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol 2000; 45: 195.","journal-title":"Surv Ophthalmol"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.msec.2016.09.064","article-title":"Multifunctional theranostic Pluronic mixed micelles improve targeted photoactivity of Verteporfin in cancer cells","volume":"71","author":"Pellosi D.S.","year":"2017","unstructured":"Pellosi D.S., Calori I.R., de Paula L.B., Hioka N., Quaglia F. and Tedesco A.C.: Multifunctional theranostic Pluronic mixed micelles improve targeted photoactivity of Verteporfin in cancer cells. Mater Sci Eng C Mater Biol Appl 2017; 71: 1.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psym.2020.05.013","article-title":"Neurocovid: Pharmacological Recommendations for Delirium Associated With COVID-19","volume":"61","author":"Baller E.B.","year":"2020","unstructured":"Baller E.B., Hogan C.S., Fusunyan M.A., Ivkovic A., Luccarelli J.W., Madva E. et al: Neurocovid: Pharmacological Recommendations for Delirium Associated With COVID-19. Psychosomatics 2020; 61: 585.","journal-title":"Psychosomatics"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113793"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10557-020-07066-x","article-title":"Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19","volume":"35","author":"Aliter K.F.","year":"2021","unstructured":"Aliter K.F. and Al-Horani R.A.: Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19. Cardiovasc Drugs Ther 2021; 35: 195.","journal-title":"Cardiovasc Drugs Ther"},{"key":"e_1_3_4_41_2","doi-asserted-by":"crossref","unstructured":"Vatansever EC Yang K Kratch KC Drelich A Cho C-C Mellot DM et al. Targeting the SARS-CoV-2 Main Protease to Repurpose Drugs for COVID-19. bioRxiv 2020. https:\/\/doi.org\/10.1101\/2020.05.23.112235.","DOI":"10.1101\/2020.05.23.112235"},{"key":"e_1_3_4_42_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fphar.2019.00071","article-title":"Computational Identification of Inhibitors Using QSAR Approach Against Nipah Virus","volume":"10","author":"Rajput A.","year":"2019","unstructured":"Rajput A., Kumar A. and Kumar M.: Computational Identification of Inhibitors Using QSAR Approach Against Nipah Virus. Front Pharmacol 2019; 10: 71.","journal-title":"Front Pharmacol"},{"key":"e_1_3_4_43_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-85280-9","article-title":"Computational evidence for nitro derivatives of quinoline and quinoline N-oxide as low-cost alternative for the treatment of SARS-CoV-2 infection","volume":"11","author":"Assis L.C.","year":"2021","unstructured":"Assis L.C., de Castro A.A., de Jesus J.P.A., Nepovimova E., Kuca K., Ramalho T.C. et al: Computational evidence for nitro derivatives of quinoline and quinoline N-oxide as low-cost alternative for the treatment of SARS-CoV-2 infection. Sci Rep 2021; 11.","journal-title":"Sci Rep"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2020.100094"},{"key":"e_1_3_4_45_2","first-page":"1","article-title":"High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein","author":"Awad I.E.","year":"2020","unstructured":"Awad I.E., Abu-Saleh A.-A.-A.-A., Sharma S., Yadav A. and Poirier R.A.: High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein. J Biomol Struct Dyn 2020; : 1.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.0c00397"},{"key":"e_1_3_4_47_2","doi-asserted-by":"crossref","unstructured":"Chang Y-C Hsiao Y Lee K-H Hsiao Y-C Lin Y-H et al. DockCoV2: a drug database against SARS-CoV-2. Nucleic Acids Res 2021;49:D1152\u20139.","DOI":"10.1093\/nar\/gkaa861"},{"key":"e_1_3_4_48_2","doi-asserted-by":"crossref","unstructured":"Guedes IA Costa LSC Dos Santos KB Karl ALM Rocha GK Teixeira IM et al. Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants. Sci Rep 2021;11:5543.","DOI":"10.1038\/s41598-021-84700-0"},{"key":"e_1_3_4_49_2","doi-asserted-by":"crossref","unstructured":"Li R Li Y Liang X Yang L Su M Lai KP. Network Pharmacology and bioinformatics analyses identify intersection genes of niacin and COVID-19 as potential therapeutic targets. Brief Bioinform 2021;22:1279\u201390.","DOI":"10.1093\/bib\/bbaa300"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2020.12.028"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2020.03.025"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-020-0153-3"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21707"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1897\/01-171"},{"key":"e_1_3_4_55_2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cbdd.12834","article-title":"AVCpred: an integrated web server for prediction and design of antiviral compounds","volume":"89","author":"Qureshi A.","year":"2017","unstructured":"Qureshi A., Kaur G. and Kumar M.: AVCpred: an integrated web server for prediction and design of antiviral compounds. Chem Biol Drug Des 2017; 89: 74.","journal-title":"Chem Biol Drug Des"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-3-33"},{"key":"e_1_3_4_57_2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/978-0-387-30162-4_415","volume-title":"Encyclopedia of Algorithms","author":"Cristianini N.","year":"2008","unstructured":"Cristianini N. and Ricci E.: Encyclopedia of Algorithms. Boston, MA: Springer US 2008: 928."},{"key":"e_1_3_4_58_2","article-title":"Machine Learning with Scikit-Learn and Tensorflow: Deep Learning with Python (Random Forests","author":"Maxwell E.H.","year":"2019","unstructured":"Maxwell E.H.: Machine Learning with Scikit-Learn and Tensorflow: Deep Learning with Python (Random Forests. Decision Trees, and Neural Networks). Independently Published 2019; .","journal-title":"Decision Trees, and Neural Networks). Independently Published"},{"key":"e_1_3_4_59_2","first-page":"83","volume-title":"k-Nearest Neighbor Classification. Data Mining in Agriculture","author":"Mucherino A.","year":"2009","unstructured":"Mucherino A., Papajorgji P.J. and Pardalos P.M.: k-Nearest Neighbor Classification. Data Mining in Agriculture. New York, NY: Springer 2009: 83."},{"key":"e_1_3_4_60_2","doi-asserted-by":"crossref","unstructured":"Daniel GG. Artificial Neural Network. Encyclopedia of Sciences and Religions Springer Dordrecht; 2013 p. 143\u2013143.","DOI":"10.1007\/978-1-4020-8265-8_200980"},{"key":"e_1_3_4_61_2","unstructured":"G\u00e9ron A. Hands-On Machine Learning with Scikit-Learn Keras and TensorFlow: Concepts Tools and Techniques to Build Intelligent Systems. \u201cO\u2019Reilly Media Inc.\u201d; 2019."},{"key":"e_1_3_4_62_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jchromb.2012.05.020","article-title":"A support vector machine-recursive feature elimination feature selection method based on artificial contrast variables and mutual information","volume":"910","author":"Lin X.","year":"2012","unstructured":"Lin X., Yang F., Zhou L., Yin P., Kong H., Xing W. et al: A support vector machine-recursive feature elimination feature selection method based on artificial contrast variables and mutual information. J Chromatogr B Analyt Technol Biomed Life Sci 2012; 910: 149.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"e_1_3_4_63_2","first-page":"5258","article-title":"Recursive feature elimination for brain tumor classification using desorption electrospray ionization mass spectrometry imaging","volume":"2012","author":"Gholami B.","year":"2012","unstructured":"Gholami B., Norton I., Tannenbaum A.R. and Agar N.Y.R.: Recursive feature elimination for brain tumor classification using desorption electrospray ionization mass spectrometry imaging. Conf Proc IEEE Eng Med Biol Soc 2012; 2012: 5258.","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"e_1_3_4_64_2","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/bioinformatics\/btw783","article-title":"RADER: a RApid DEcoy Retriever to facilitate decoy based assessment of virtual screening","volume":"33","author":"Wang L.","year":"2017","unstructured":"Wang L., Pang X., Li Y., Zhang Z. and Tan W.: RADER: a RApid DEcoy Retriever to facilitate decoy based assessment of virtual screening. Bioinformatics 2017; 33: 1235.","journal-title":"Bioinformatics"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr320"},{"key":"e_1_3_4_66_2","doi-asserted-by":"crossref","unstructured":"Wishart DS Feunang YD Guo AC Lo EJ Marcu A Grant JR et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 2018;46:D1074\u201382.","DOI":"10.1093\/nar\/gkx1037"},{"key":"e_1_3_4_67_2","doi-asserted-by":"crossref","unstructured":"Morris GM Huey R Lindstrom W Sanner MF Belew RK Goodsell DS et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785\u201391.","DOI":"10.1002\/jcc.21256"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.03.045"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104365"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S200103702100218X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S200103702100218X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2021.05.037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:47:20Z","timestamp":1779022040000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2021.05.037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":69,"alternative-id":["10.1016\/j.csbj.2021.05.037"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2021.05.037","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2021.05.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}